It’s not often that management talks up the challenges facing the business they head. Since the 250p-a-share offer failed to win enough support in the shareholder vote this month, some heat remains in the private hospital operator’s share price. At 223p, the shares are trading at a near two-year high after a torrid performance in recent years. SponsoredThe recovery rally did predate the takeover interest from its Australian rival. A higher proportion of self-paying patients and

Source: The Times July 26, 2021 22:52 UTC